Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:1901214 | regulation of neuron death | 33/819 | 313/18670 | 0.00000308 | 0.0003125 | 0.0002397 | 33 | RABC5 | |
BP | GO:0032869 | cellular response to insulin stimulus | 26/819 | 216/18670 | 0.00000312 | 0.0003125 | 0.0002397 | 26 | RABC5 | |
BP | GO:0006790 | sulfur compound metabolic process | 37/819 | 372/18670 | 0.00000316 | 0.0003125 | 0.0002397 | 37 | RABC5 | |
BP | GO:0006732 | coenzyme metabolic process | 39/819 | 403/18670 | 0.00000335 | 0.0003227 | 0.0002475 | 39 | RABC5 | |
BP | GO:0060337 | type I interferon signaling pathway | 16/819 | 95/18670 | 0.00000349 | 0.0003227 | 0.0002475 | 16 | RABC5 | |
BP | GO:0071357 | cellular response to type I interferon | 16/819 | 95/18670 | 0.00000349 | 0.0003227 | 0.0002475 | 16 | RABC5 | |
BP | GO:0001935 | endothelial cell proliferation | 24/819 | 191/18670 | 0.0000035 | 0.0003227 | 0.0002475 | 24 | RABC5 | |
BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 16/819 | 96/18670 | 0.00000402 | 0.0003639 | 0.0002791 | 16 | RABC5 | |
BP | GO:0001654 | eye development | 36/819 | 362/18670 | 0.0000043 | 0.0003803 | 0.0002917 | 36 | RABC5 | |
BP | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 17/819 | 108/18670 | 0.00000453 | 0.0003803 | 0.0002917 | 17 | RABC5 | |
BP | GO:0070997 | neuron death | 35/819 | 348/18670 | 0.00000454 | 0.0003803 | 0.0002917 | 35 | RABC5 | |
BP | GO:0030111 | regulation of Wnt signaling pathway | 36/819 | 363/18670 | 0.00000458 | 0.0003803 | 0.0002917 | 36 | RABC5 | |
BP | GO:0050678 | regulation of epithelial cell proliferation | 37/819 | 378/18670 | 0.00000458 | 0.0003803 | 0.0002917 | 37 | RABC5 | |
BP | GO:0007044 | cell-substrate junction assembly | 16/819 | 97/18670 | 0.00000462 | 0.0003803 | 0.0002917 | 16 | RABC5 | |
BP | GO:0009205 | purine ribonucleoside triphosphate metabolic process | 34/819 | 335/18670 | 0.00000508 | 0.0004125 | 0.0003164 | 34 | RABC5 | |
BP | GO:0006885 | regulation of pH | 16/819 | 98/18670 | 0.0000053 | 0.000418 | 0.0003206 | 16 | RABC5 | |
BP | GO:0071375 | cellular response to peptide hormone stimulus | 33/819 | 321/18670 | 0.00000531 | 0.000418 | 0.0003206 | 33 | RABC5 | |
BP | GO:0051216 | cartilage development | 25/819 | 209/18670 | 0.00000538 | 0.000418 | 0.0003206 | 25 | RABC5 | |
BP | GO:0150063 | visual system development | 36/819 | 366/18670 | 0.00000551 | 0.0004223 | 0.0003239 | 36 | RABC5 | |
BP | GO:0090175 | regulation of establishment of planar polarity | 17/819 | 110/18670 | 0.00000585 | 0.0004365 | 0.0003348 | 17 | RABC5 | |
BP | GO:0030178 | negative regulation of Wnt signaling pathway | 25/819 | 210/18670 | 0.00000586 | 0.0004365 | 0.0003348 | 25 | RABC5 | |
BP | GO:1904035 | regulation of epithelial cell apoptotic process | 15/819 | 88/18670 | 0.00000601 | 0.0004396 | 0.0003371 | 15 | RABC5 | |
BP | GO:0034340 | response to type I interferon | 16/819 | 99/18670 | 0.00000606 | 0.0004396 | 0.0003371 | 16 | RABC5 | |
BP | GO:0009167 | purine ribonucleoside monophosphate metabolic process | 34/819 | 340/18670 | 0.00000701 | 0.0005008 | 0.0003841 | 34 | RABC5 | |
BP | GO:0030203 | glycosaminoglycan metabolic process | 21/819 | 160/18670 | 0.00000711 | 0.0005008 | 0.0003841 | 21 | RABC5 | |
BP | GO:0051495 | positive regulation of cytoskeleton organization | 26/819 | 226/18670 | 0.00000718 | 0.0005008 | 0.0003841 | 26 | RABC5 | |
BP | GO:0051188 | cofactor biosynthetic process | 33/819 | 326/18670 | 0.00000737 | 0.0005019 | 0.0003849 | 33 | RABC5 | |
BP | GO:0009126 | purine nucleoside monophosphate metabolic process | 34/819 | 341/18670 | 0.00000747 | 0.0005019 | 0.0003849 | 34 | RABC5 | |
BP | GO:0048880 | sensory system development | 36/819 | 371/18670 | 0.00000748 | 0.0005019 | 0.0003849 | 36 | RABC5 | |
BP | GO:0006914 | autophagy | 44/819 | 496/18670 | 0.0000078 | 0.0005056 | 0.0003877 | 44 | RABC5 |